1.Transfusion Therapy in a Patient with Hemolytic Transfusion Reaction due to Anti-Jka.
Tae Sung PARK ; Sang Youn HWANG ; Hyung Hoi KIM ; Yun Seong KIM ; Soon Kew PARK ; Eun Yup LEE ; Han Chul SON
Korean Journal of Blood Transfusion 2003;14(1):60-64
No abstract available.
Blood Group Incompatibility*
;
Humans
2.A Case of Delayed Hemolytic Transfusion Reaction due to Anti-N.
Ji Weon SEO ; Me Eun CHUNG ; Jong Won LEE ; Kyou Sup HAN
Korean Journal of Blood Transfusion 2008;19(1):63-66
No abstract available.
Blood Group Incompatibility
3.A case of delayed hemolytic transfusion reaction due to anti-C(rh').
Pan Gyu KIM ; Suk Joon PACK ; Jeong Deuk LEE ; Hae Kyung LEE ; Chul Soo CHO ; Jung Min SUH ; Dong Jun PARK ; Kyu Sik SHIM
Korean Journal of Medicine 1993;45(1):118-122
No abstract available.
Blood Group Incompatibility*
4.A case of delayed hemolytic transfusion reaction due to anti-e identified by bromelin treatment.
You Kyoung LEE ; Yeon Sun KIM ; Jee Young AHN ; Hwi Jun KIM ; Seong Gyu HWANG
Korean Journal of Blood Transfusion 1992;3(2):185-189
No abstract available.
Blood Group Incompatibility*
;
Bromelains*
5.An Anesthetic Experience of a Patient with Cis A2B3 Blood Type.
Korean Journal of Anesthesiology 2001;40(1):95-99
Cis A2B3 is a rare blood type with unusual inheritance pattern of A2, B3 genes on the same chromosome in contradiction to the general Mendelian pattern. Unlike the AB blood type, cis A2B3 shows weaker B antigenicity and unexpectedly has moderate amount of anti-B antibody in serum. Thus it has the potential of misidentification as blood type A or AB and the possibility of acute major transfusion reaction from transfusion of the usually known AB blood group RBCs. This is a case report of anesthetic management of one patient with his blood type discovered as cis A2B3 preoperatively. During hip surgery he received 2 units of washed O RBCs without any problems. I report the anesthetic experience with a brief review of literature.
Blood Group Incompatibility
;
Hip
;
Humans
;
Inheritance Patterns
6.Use of blood components, irradiated and filtered blood products in Chonnam University Hospital.
Sang Khoo LEE ; Mee Jeong JEON ; Jong Hee SHIN ; Soon Pal SUH ; Dong Wook RYANG
Korean Journal of Blood Transfusion 1997;8(2):43-50
BACGROUND: Recently, transfusion by component blood products instead of whole blood has gradually increased. And also filtered and/or irradiated blood products for the prevention of GVHD and other transfusion reaction has been used. To probe trends of recent transfusion, we analysed the use of blood components from 1989 through 1996 in Chonnam University Hospital. METHODS: We reviewed blood bank records from 1989 through 1996 in Chonnam University Hospital. RESULTS: 1. Total numbers of transfused blood units from 1989 to 1996 were 369,326 and the rate of component transfusion increased from 24.5% (1989) to 99.6% (1996) in Chonnam University Hospital. 2. Total numbers of transfused whole bloods were 5,569 units (24.5%) in 1989, then declined to 327 units (0.5%) in 1996. 3. Transfusion of PRC increased from 9,325 units (41.1%) in 1989 to 24,368 units (35.8%) in 1996, and also FFP from 7,371 units (32.4%) in 1989 to 15,546 units (22.9%) in 1996. 4. Use of platelet concentrates increased 16.4-fold from 2,223 units (2.5%) in 1989 to 36,531 units (46.8%) in 1996. 5. In 1996, percentage of filtered and irradiated blood products was 32.3% from cellular blood products. 6. With the use of the advanced blood seperator, hemapheresis showed slight increase annually. CONCLUSION: This paper will provide the basis of blood supply in Chonnam University Hospital and blood center.
Blood Banks
;
Blood Group Incompatibility
;
Blood Platelets
;
Jeollanam-do*
7.The Frequency and Distribution of Unexpected Red Cell Antibodies at National Cancer Center.
Byeong Min PARK ; Yoon Kyung SONG ; Taek Soo KIM ; Gun Ho LEE ; Ji Seon CHOI ; Moon Woo SEONG ; Do Hoon LEE ; Sun Young KONG
Korean Journal of Blood Transfusion 2009;20(2):120-128
BACKGROUND: Performing antibody screening and identification tests before blood transfusion are important since unexpected red cell antibodies can cause acute or delayed hemolytic transfusion reactions. We investigated the frequency and distribution of unexpected red cell antibodies that were detected in cancer patients at National Cancer Center (NCC) and we compared our results with the previously published data. METHODS: From January 2001 to June 2009, 56,660 sera of the cases from NCC were screened and 197 sera were identified with using the Ortho BioVue System (Ortho-Clinical Diagnostics, Raritan, USA) and the conventional tube method. In case of the presence of autoantibody, the ZZAP method was performed to distinguish alloantibody from autoantibody. RESULTS: 759 cases (1.34%) showed positive results out of all 56,660 cases that underwent unexpected antibodies screening. Among them, unexpected antibodies were identified in 197 cases. The most frequently detected antibody was anti-Le(a) in 62 cases (31.47%), followed by anti-E in 32 cases (16.24%) and anti-Le(b) in 18 cases (9.14%). Unidentified antibodies were detected in 43 cases (21.83%). In the cases with a previous history of transfusion at the NCC and the screening results were altered from negative to positive, anti-E was the most frequently detected antibody (8/30 cases, 26.67%), and this included the mixed antibodies. CONCLUSION: Compared with the previous reports, this study showed that the frequency and distribution of the unexpected red cell antibodies of cancer patients were not different from those of general patients. Moreover, there was no apparent difference of frequency of the unexpected red cell antibodies among the diagnosed cancers. Our research may provide data for the frequency and characteristics of red cell antibodies because we targeted only cancer patients.
Antibodies
;
Blood Group Incompatibility
;
Blood Transfusion
;
Humans
;
Mass Screening
8.Guidelines for Appropriate and Safe Transfusion.
Journal of the Korean Medical Association 2006;49(5):391-401
Transfusion can cause transfusion-transmitted diseases and various transfusion reactions. Recent improvements in the safety of blood supply and the increasing costs associated with transfusion therapies have led to a re-evaluation of the clinical practices of blood transfusion and blood conservation, which need practical guidelines for the use of constituent parts of blood. The traditional threshold of the hemoglobin concentration at 10g /dL for RBC transfusion has moved down to 7g /dL, and that of the platelet count at 20 x 10(9)/L for platelet transfusion can also be lowered to 5 x 10(9)/L. To improve the transfusion practice, as recommended by the guidelines, a prospective audit allied to educational programs can be effective in modifying the clinicians' practices of requesting transfusions.
Blood Group Incompatibility
;
Blood Transfusion
;
Platelet Count
;
Platelet Transfusion
9.The Frequency of Unexpected Antibodies in Transfusion Candidates in Recent 6 Years.
Myeong Hee KIM ; Jin Tae SUH ; Woo In LEE
Korean Journal of Blood Transfusion 2004;15(2):162-167
BACKGROUND: Antibody screening and identification tests are indispensable test to protect hemolytic transfusion reaction. Due to increase of transfusion and development of new techniques for detection of antibodies, the incidence of unexpected antibodies may tend to increase compared with the past. METHODS: We evaluated the frequency and distribution of unexpected antibodies by two methods from 53,167 sera. The tube(saline, albumin, and antiglobulin phase) methods were subjected to the sera from Jan 1998 to April 2000, and gel agglutination methods with DiaMed-ID system (DiaMed, Murten, Switzerland) were subjected to the sera from May 2000 to Feb 2004. RESULTS: Out of all 53,167 serum samples, positive results were obtained from 177 sera(0.33%). Antibody that was detected most frequently was anti-E(46 sera, 25.9%), followed by anti-Le a (43 sera, 22.6%), anti-Le b and anti-c. In the tube method, 55 cases(83.3%) were detected at antiglobulin phase. Among the patients with unexpected antibodies, 85 cases(54.5%) had the history of previous transfusion. CONCLUSION: Unexpected antibodies that were detected in this study were mostly significant antibodies in clinical. There was no difference of the frequency according to the method. Unexpected antibodies were associated with multiple transfusion. Therefore antibody screening and identification tests are critical step in pre-transfusion tests.
Agglutination
;
Antibodies*
;
Blood Group Incompatibility
;
Humans
;
Incidence
;
Mass Screening
10.Prestorage leukoreduced RBCs: Evaluation for two different quadruple collection bags with an inline RBC filter.
Mi Kyung LEE ; Dae Sung KIM ; Nam Sun CHO ; Hyun Ok KIM ; Dae Won KIM
Korean Journal of Blood Transfusion 2003;14(1):44-54
BACKGROUND: The Korean Red Cross(KRC) are considering the introduction of prestorage leukoreduced RBCs, as it is thought one of best way to prevent WBC-associated adverse transfusion reactions. We evaluated two different quadruple top-and-bottom collection bags, specially designed for this purpose by two manufacturers(Boin Medica Co.,Ltd and Green Cross Medical Corporation, Korea), consisted of a CPD bag, a SAG-M bag and an inline RBC filter, either RCM1 (Pall Medical, U.S.A.) or BioR 01 1N (Fresenius Hemocare, Germany) each. METHODS: Fifty one bags from Boin and sixty bags from Green Cross and consequent blood components were studied in twice over a period of two years. As an inline filter, Boin used RCM1 and Green Cross used RCM1(1st) and BioR 01 1N(2nd). They were divided into group A(filtration performed after processing of RBCs) and B(filtration performed after storage of overnight at 4 degrees C). WBC-reduced RBCs were tested for pH, plasma K+, plasma Hb and blood culture every 7 days to investigate storage time-dependent changes up to 42 days. RESULTS: The results of pH, plasma K+ and plasma Hb from CPD added whole blood, RBCs, SAG-M added RBCs and WBC-reduced RBCs did not show significant differences. We observed both of adding SAG-M solution and filtration procedure did not effect on the prestorage leukoreduced RBCs. WBCs were removed effectively by prestorage filtration. But in the case of failed units, the design or method to integrate an RBC filter may be a cause for the failure. CONCLUSION: We concluded that two different quadruple collection bags with integral RCM1 filter from Boin(2nd) and Green Cross(1st) are useful for production of prestorage leukoreduced RBCs.
Blood Group Incompatibility
;
Filtration
;
Hydrogen-Ion Concentration
;
Plasma